Acumen Pharmaceuticals (ABOS) Share-based Compensation (2020 - 2026)
Acumen Pharmaceuticals (ABOS) posted Share-based Compensation of $2.52 million for Q2 2026, up 1.0% from $2.5 million a year earlier and up 5.3% from the prior quarter.
Powered by 
Analysis
Acumen Pharmaceuticals (ABOS) Share-based Compensation (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Acumen Pharmaceuticals was $9.8 million, up 1.5% year-over-year; for FY2025, it was $9.85 million, up 2.3% from FY2024.
- Annual Share-based Compensation has increased for five consecutive years, with a five-year compound annual growth rate of 129.7% (FY2020 to FY2025).
- In prior years, Acumen Pharmaceuticals' Share-based Compensation was $9.64 million in FY2024 (+56.8%), $6.15 million in FY2023 (+100.8%), $3.06 million in FY2022 (+232.0%) and $922,000 in FY2021 (+498.7%).
- The Q2 2026 figure stands as the highest quarterly Share-based Compensation in data going back to Q3 2020.
- On a year-over-year basis, Share-based Compensation increased in six of the last eight quarters, with growth averaging 12.1%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2021, with growth of 860.5%; the weakest was Q1 2026, with a decline of 3.2%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $2.4 million (Q1 2026), $2.42 million (Q4 2025) and $2.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.99 Bn | 1,139.58 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 642.25 Bn | 560.77 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 502.08 Bn | 475.19 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 375.61 Bn | 329.99 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.76 Bn | 266.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.66 Bn | 242.35 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.98 Bn | 197.38 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 193.37 Bn | 167.57 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.42 Bn | 119.07 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Acumen Pharmaceuticals | 150.64 Mn | -331.43 Mn | - | 2.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.52 Mn |
| Mar 31, 2026 | 2.40 Mn |
| Dec 31, 2025 | 2.42 Mn |
| Sep 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.47 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 888,000.00 |
| Sep 30, 2022 | 840,000.00 |
| Jun 30, 2022 | 715,000.00 |
| Mar 31, 2022 | 618,000.00 |
| Dec 31, 2021 | 365,000.00 |
| Sep 30, 2021 | 304,000.00 |
API Access
Acumen Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ABOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();